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Intravascular large B cell lymphoma (IVLBL) is a rare, ag-
gressive hematologic neoplasm characterized by the selective 
proliferation of neoplastic lymphoid cells within the lumina of 
small or intermediate sized vessels [1]. Most cases occur in adults, 
with a median age of 67 years [1]. Men and women are equally 
affected [2]. Clinically, IVLBL is often called ‘oncologist’s great 
imitator’, since it can affect various organs and manifest diverse 
symptoms according to the types of organs involved [3]. Cen-
tral nervous system (CNS) and skin involvements are relatively 
frequent. However, renal involvement is rare [4]. In addition, fever, 
hepatosplenomegaly, pancytopenia, or even multiorgan failure 
may occur [5]. 
In this report, we described the first case of renal IVLBL in 
Korea occurring in a 66-year-old female. We also briefly reviewed 
42 cases of renal IVLBL that were previously published. 
CASE REPORT
A 66-year-old female was admitted to the Hematology Divi-
sion of Internal Medicine with the presentation of a fever of 38°C, 
cough, non-bloody sputum, and dyspnea, which had started a 
month previously. Her past medical history was unremarkable. 
Her blood pressure was 126/67 mm Hg, pulse rate was 79 beats 
per minute, and respiratory rate was 18 breaths per minute. The 
physical examination revealed no specific findings. Neither 
lymphadenopathy nor skin rashes were noted. The analysis of 
the complete blood cell count revealed anemia (hemoglobin, 
7.1 g/dL) and thrombocytopenia (platelet count, 95 × 103/μL). 
Ferritin was 1,003.0 ng/mL. Serum haptoglobin level was nor-
mal and the Coombs test was negative. The C-reactive protein 
level was 86.7 mg/L and the lactate dehydrogenase level was 
1,779 U/L. Blood urea nitrogen and serum creatinine levels 
were 2.8 mmol/L and 0.75 mg/dL, respectively. Serum aspartate 
transaminase was 31 IU/L and alanine transaminase was 10 IU/L. 
Total bilirubin level was mildly elevated (1.5 mg/dL). Antinu-
clear antibodies, anti-neutrophil cytoplasmic antibodies, anti-
glomerular basement antibody, and hepatitis B and C viral 
markers were all negative. Sputum, blood, and urine cultures 
revealed all negative results. Chest computed tomography (CT) 
showed mild bronchiolitis in the right upper lobe field without 
definite evidence of pulmonary thromboembolism. Abdominal 
CT revealed mild hepatosplenomegaly. On the positron emis-
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sion tomography–CT, diffuse 18F-Fluorodeoxyglucose (FDG) 
uptake on the bilateral lungs, mild FDG uptake on the left lat-
eral segment of the liver, and increased FDG uptake along the 
axial and appendicular bones were noted (Fig. 1). Clinically, 
hemophagocytic lymphohistiocytosis was suggested. A subse-
quent bone marrow biopsy revealed normocellular marrow 
without abnormal cell infiltration. Liver biopsy showed mild 
lobular hepatitis with Kupffer cell hypertrophy and increased 
hemophagocytosis. 
During further work ups, heavy proteinuria (4 g/day and 
urine protein-to-creatinine ratio of 4.94) suddenly developed. A 
renal biopsy was performed on the twenty-fourth hospital day. 
The biopsy core of the kidney contained nineteen glomeruli. 
Most of the glomeruli were mildly enlarged and hypercellular 
with infiltration of atypical large lymphoid cells in the capillary 
lumina. They exhibited a high nucleus-cytoplasm ratio with 
size variation, chromatin clumping, and inconspicuous nucleoli. 
Immunohistochemical stains demonstrated strong CD20 and 
CD79a membranous positivity with a Ki-67 proliferation in-
dex of 80% (Fig. 2). The tubulointerstitium was relatively well-
preserved, but the tumor cells were also present in some peritu-
bular capillaries. On electron microscopy, the glomerular capillary 
lumen was obliterated by swollen endothelial cells and infiltrat-
ing atypical lymphoid cells (Fig. 3). The diagnosis of renal in-
travascular large B cell lymphoma was confirmed. The patient 
is currently receiving chemotherapy consisting of rituximab, 
cyclophosphamide, doxorubicin, vincristine, and prednisolone 
(R-CHOP) with close follow-ups for three months. 
DISCUSSION
IVLBL is a rare type of aggressive, non-Hodgkin B cell lym-
phoma that is confined to small to medium sized vessels. Clini-
cally, two major patterns have been recognized [6]. The first pat-
tern, called the ‘Classic form’, is prevalent in Western populations 
and usually demonstrates skin and CNS involvement and related 
symptoms. The second pattern, so called the ‘Asian variant’, is 
characterized by hemophagocytic syndrome, fever, multiorgan 
failure, hepatosplenomegaly, and bone marrow involvement. 
Our case exhibited clinical features of the ‘Asian variant’ with 
fever, hepatosplenomegaly, and nephrotic range proteinuria. 
Renal involvement of IVLBL is infrequent. Forty-three cases, 
including the present case, have been reported in English litera-
ture (Table 1). There were 19 males and 21 females, ranging from 
35 to 85 years of age (mean age, 60.5 years). The clinical signs of 
renal involvement were proteinuria (90.0%), some with nephrotic 
range (21.0%), renal failure (60.5%), and enlargement of the 
kidney upon radiologic evaluation (34.3%). Fifty percent of the 
cases also exhibited extrarenal involvement. Bone marrow in-
volvement was identified in three out of 16 cases. Hemophago-
cytosis was observed in four cases, including the present case. 
All four cases occurred in Asians.
Histologically, malignant lymphoid cells demonstrate gener-
ally large, vesicular nuclei, one or more nucleoli, and scanty cy-
toplasm [1]. These cells usually express pan B cell markers in-
cluding CD20, CD79a, and bcl-2, bcl-6, MUM-1, and variable 
expressions of CD5 and CD10 [7]. Although glomerular hyper-
cellularity can be seen in hemophagocytic lymphohistiocytosis, 
cellular atypia and immunohistochemistry could differentiate 
malignant B lymphocytes from macrophages. Neoplastic cells 
lack surface molecules including CD29, CD54, and CD49d, fa-
cilitating the transvascular migration of the tumor cells. The 
aberrant expression of CXCR3 has also been described [8].
Of the 43 cases of intrarenal IVLBL with histologic descrip-
tions, 35 cases exhibited the glomerular infiltration of tumor 
cells with or without peritubular and interstitial involvement. 
In four cases, the tumor cells were localized in peritubular cap-
Fig. 1. Positron emission tomography (PET) images (18F-Fluorode-
oxyglucose PET). (A) Maximal intensity projection image. PET–
computed tomography image of the lung (B), liver (C), and axial 
bones (D). 
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Fig. 2. Histopathologic findings and immunohistochemical staining results of renal intravascular large B cell lymphoma. (A) Atypical large 
lymphoid cells are confined to the lumina of the glomerular capillaries. (B) On higher magnification, malignant lymphoid cells exhibited nuclear 
size variation, chromatin clumping, and scant cytoplasm. (C) Some atypical lymphoid cells are scattered in the peritubular capillaries. On im-
munohistochemical staining, these atypical lymphoid cells demonstrated strong membranous positivity for CD20 (D) and CD79a (E). (F) The 
Ki-67 proliferation index was 80%. 
illaries without glomerular involvement. Our case showed glo-
merular and peritubular involvement. The microvascular infil-
tration and obliteration by tumor cells may be responsible for 
proteinuria in our case through podocyte and endothelial inju-
ries [9].
IVLBL generally shows aggressive clinical courses, often wors-
Fig. 3.  Representative electron microscopy of the kidney. (A) Atypical large lymphoid cells are present in the glomerular capillary lumen, and 
the podocytes exhibit diffuse foot process effacement (× 1,500). (B) On high power magnification, the atypical large lymphoid cell (arrow) 
shows prominent nucleoli and chromatin clumping (× 3,000).
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ened by the delay of diagnosis due to its nonspecific clinical 
presentation [10]. In terms of prognosis, at 6 months after diag-
nosis, 15 patients were alive and seven patients had died. Recently, 
rituximab-based chemotherapy has significantly improved clinical 
outcomes with a 3-year survival rate of 60%–80%. In addition, 
IVLBL only limited to the skin has been reported to exhibit 
better prognoses [11]. Our case is under rituximab-based che-
motherapy for 3 months without further clinical deterioration.
In summary, we described a case of the renal involvement of 
IVLBL. Although the renal involvement of IVLBL is rare, this 
entity should be included as a differential diagnosis if unex-
plained hemophagocytic syndrome coupled with proteinuria 
persists.
Supplementary Information
The Data Supplement is available with this article at https://doi.org/10.4132/
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